MENU
MRSN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Mersana Therapeutics (MRSN) Earnings Date & Reports

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

MRSN is expected to report earnings to rise 76.64% to -19 cents per share on May 12

Mersana Therapeutics MRSN Stock Earnings Reports
Q1'25
Est.
$-0.19
Q4'24
Beat
by $0.04
Q3'24
Missed
by $0.18
Q2'24
Missed
by $0.03
Q1'24
Beat
by $0.02
The last earnings report on March 03 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 2.55M shares outstanding, the current market capitalization sits at 38.15M.
View a ticker or compare two or three
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of antibody drug conjugates to improve patient outcomes in multiple oncology indications

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
840 Memorial Drive
Phone
+1 617 498-0020
Employees
123
Web
https://www.mersana.com